Cooper Companies' (COO) "Hold" Rating Reiterated at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Cooper Companies (NASDAQ:COO - Free Report) in a report issued on Friday morning,Benzinga reports.

COO has been the subject of several other research reports. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research note on Friday, December 6th. Morgan Stanley cut their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Finally, Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and an average price target of $111.89.

Remove Ads

Cooper Companies Stock Up 1.4 %

NASDAQ:COO traded up $1.14 during mid-day trading on Friday, hitting $81.03. The stock had a trading volume of 3,370,815 shares, compared to its average volume of 1,725,305. Cooper Companies has a twelve month low of $78.43 and a twelve month high of $112.38. The stock has a 50-day simple moving average of $92.14 and a two-hundred day simple moving average of $99.34. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $16.17 billion, a PE ratio of 41.55, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, equities research analysts anticipate that Cooper Companies will post 3.98 EPS for the current year.

Hedge Funds Weigh In On Cooper Companies

Several institutional investors have recently added to or reduced their stakes in the stock. Ashton Thomas Securities LLC purchased a new stake in shares of Cooper Companies during the third quarter worth approximately $25,000. Byrne Asset Management LLC acquired a new position in Cooper Companies in the 4th quarter valued at $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies during the 4th quarter worth $34,000. Covestor Ltd lifted its stake in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after acquiring an additional 200 shares during the period. Finally, New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies in the fourth quarter valued at about $38,000. Institutional investors and hedge funds own 24.39% of the company's stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.